Research programme: osteoarthritis therapy - Celestar Lexico-Sciences

Drug Profile

Research programme: osteoarthritis therapy - Celestar Lexico-Sciences

Alternative Names: Osteoarthritis therapy research programme - Celestar Lexico-Sciences

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Celestar Lexico-Sciences
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Osteoarthritis

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Osteoarthritis in Japan
  • 15 Apr 2005 Celestar Lexico-Sciences' osteoarthritis therapy research programme is available for partnering for target identification/validation (
  • 15 Apr 2005 Preclinical trials in Osteoarthritis in Japan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top